News Industry News TCT 2016 Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures November 01, 2016
News Daily News New Guideline Gives the Greenlight to Calcium Supplements Caitlin E. Cox October 26, 2016
News Daily News Socioeconomic Standing May Affect Statin Adherence in Men, With Unclear Consequences in Women Yael L. Maxwell October 25, 2016
News Daily News La Situación Socioeconómica podría Afectar a la Adherencia a las Estatinas en Hombres, Con Consecuencias Poco Claras en Mujeres Yael L. Maxwell October 25, 2016
News Daily News Calcium Supplements, but Not Dietary Calcium, Linked to Higher Long-term Risk of Atherosclerosis: MESA Caitlin E. Cox October 18, 2016
News Daily News Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation Michael O'Riordan October 07, 2016
News Daily News Low Diastolic Blood Pressure Linked to Subclinical Myocardial Damage and Coronary Events: ARIC Analysis Michael O'Riordan October 06, 2016
News Features Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways Michael O'Riordan October 05, 2016
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests Todd Neale September 26, 2016
News Daily News Early-Onset Menopause Linked With Poor Cardiovascular Outcomes Yael L. Maxwell September 15, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Daily News Aortic Complications Spike for Women During Pregnancy and Shortly After Giving Birth Caitlin E. Cox August 09, 2016
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016
News Daily News Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER Michael O'Riordan June 14, 2016
News Conference News EAS 2016 Better Knowledge of Sex-Specific Differences in CV Risk Factors and Symptoms Could Save Lives, Improve Care Yael L. Maxwell June 02, 2016
News Daily News Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD Todd Neale May 27, 2016
News Daily News Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates Michael O'Riordan May 17, 2016